BETRAYED BY THE VA Thomas Alan Bowman Sr. asked his country for help. He got silence. Sign the demand →
Dear Doug Collins

The Edgewood Test Subjects: They Volunteered, Were Sworn to Silence, and Spent Fifty Years Proving It Happened

They answered a call for volunteers. At Edgewood Arsenal, on the Edgewood Area of Aberdeen Proving Ground in Maryland, the Army gave them nerve agents, mustard agents, and some of the most powerful psychoactive drugs ever synthesized — then swore them to secrecy under threat of court-martial and sent them back to their units, many of them to Vietnam. For more than three decades the oath did its work: men who believed they had been injured could not tell a doctor what had been done to them, could not prove to the Department of Veterans Affairs that it had happened at all, and were sometimes treated as fabricators when they tried. This page is the documented record of the Edgewood program, of the secrecy that outlived it by thirty years, and of the litigation — still unfinished — that has forced the institution, piece by piece, to acknowledge its own volunteers.

The service and the promise

The men were, in the Army’s own term, “soldier volunteers.” The Federal Circuit, recounting the record in Taylor v. McDonough, describes experiments from 1955 to 1975 involving “at least 6,700 ‘soldier volunteers’” exposed to “more than 250 different agents.” VA’s public health summary, citing the Department of Defense, puts the figure at about 7,000 soldiers for the classified medical studies the Army Chemical Corps conducted at Edgewood Arsenal from 1955 to 1975, to evaluate low-dose chemical warfare agents and test protective clothing and pharmaceuticals. The wider Aberdeen testing enterprise reached back further — the OATH Act’s findings describe more than 7,000 Army personnel sworn to secrecy for a program running from 1948 to 1975 — but the studies at the center of this page are the 1955–1975 program VA and DoD describe.

What the volunteers were told varied. Frank Rochelle, drafted in 1968, told DAV he volunteered from Fort Lee after seeing a bulletin for a program to test Army equipment — four-day weeks, no kitchen or guard duty — and that on arrival the mission became chemical warfare agents. Tim Josephs, a plaintiff in the later class litigation, told CNN he had expected testing of jackets, clothing, and equipment, with no mention of drugs or chemicals. Those are the men’s own accounts, given decades later, consistent on the essential point: whatever consent forms were signed at Edgewood — Bruce Taylor signed one in August 1969 confirming the experiment had been explained to him — the volunteers did not leave with a usable account of what had been put into their bodies.

The second document governed the rest of their lives. Each subject signed a secrecy oath. The sample oath printed by a Senate committee in 1976, which the Board of Veterans’ Appeals found was the oath most participants were required to sign, bound the signer not to “divulge or make available any information related to” the program to anyone “not officially authorized to receive such information,” on pain of punishment under the Uniform Code of Military Justice. The oath named no exception — not for a physician, not for the VA. Against it stood the Army’s own regulation, AR 70-25, providing that “Volunteers are authorized all necessary medical care for injury or disease that is a proximate result of their participation in research.” The promise existed on paper. The oath ensured almost no one could safely collect on it.

What happened

The testing itself is documented by VA from DoD’s records. The agents, as VA lists them, included anticholinesterase nerve agents — sarin and VX among them, in the plaintiffs’ and the courts’ accounts — and common organophosphorus and carbamate pesticides; mustard agents; antidotes including atropine and scopolamine; reactivators such as 2-PAM chloride; the incapacitating agent BZ; psychoactive agents including LSD, PCP, and cannabinoids; irritants and riot control agents; and alcohol and caffeine. Some subjects received placebos. A portion of the work, grouped under the Medical Research Volunteer Program from 1956, was directed at psychochemical warfare: finding a compound that could disable an enemy soldier’s mind rather than kill him. BZ was weaponized, though never used in combat.

The individual records show what participation could mean. Bruce Taylor, the Federal Circuit found, was exposed to at least EA-3580, an anticholinergic nerve agent, EA-3547, a tear gas agent, and scopolamine, and reported hallucinations afterward — on the rifle range, believing he was killing people rather than shooting at targets. Frank Rochelle told DAV that a drug he knew only as CAR-302,668, given as an aerosol, left him hallucinating for two and a half days, at one point trying to cut what he believed were bugs out of his own arms with a razor blade. Dave Dufrane, at Edgewood in 1965, told DAV he was experimented on eight times, placed in a padded room four times — once for four days — and temporarily blinded for eight hours by one test. These are the subjects’ accounts as reported by DAV in 2026, offered as their testimony, not as adjudicated findings. What is adjudicated is the fact VA itself states: some volunteers exhibited symptoms at the time, and “long-term follow-up was not planned as part of the DOD studies.” The men were returned to duty — Taylor and Rochelle both went on to Vietnam — carrying injuries they were forbidden to explain, into a benefits system that required them to explain exactly that.

The consequences ran on rails the oath had laid. Taylor, honorably discharged on September 6, 1971, described isolating himself, with insomnia, nightmares, depression, and auditory hallucinations; when he finally sought treatment, the Federal Circuit records, he was turned away by a provider who believed his account was a fabrication. Rochelle went to a VA clinic in 1971 after waking nearly blind in one eye; no one believed his account of Edgewood, and his first claim was denied. He filed again in 1987 — after Senate hearings had exposed the program publicly, but nineteen years before his formal release from the oath — and was finally granted service connection. Dufrane, by his account, told no one for roughly thirty years; reaching the VA in the late 1990s, he too was disbelieved at first, and won service connection only after obtaining some of his own records.

What the institution did afterward

Exposure came first, and it came from Congress, not the Army. Senate investigations in 1975–76 — the Church Committee’s 1976 report, S. Rep. No. 94-755, preserved the secrecy oath’s text itself — laid out the human testing and condemned its neglect of informed consent and follow-up. The programs were suspended in 1975. But exposure was not release: the oaths remained formally in force, and the men remained unusable witnesses to their own service.

The scientific accounting cut both ways. The National Research Council’s three-volume study, Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents (1982, 1984, and 1985), reviewed the exposures class by class and the subjects’ current health status. For the nerve agents, the first report found no evidence of adverse long-term effects but could not rule out that some agents had produced them in some individuals — a formulation that resolved nothing for a veteran who still had to prove, claim by claim, what a classified program had done to him. VA’s current summary carries the same shape: a 2016 report to DoD found no significant effects observed since the tests, which the National Academies reviewed in 2018. The subjects’ position was simpler: they had never been followed, so the absence of observed effects was the absence of observation.

The oath’s formal end came in 2006, partially, by letter. DoD declassified the volunteers’ names, and on June 30, 2006, VA wrote to participants permitting them to disclose to health care providers information about their involvement that affected their health — what they believed their exposure was, their reactions, treatment sought, and the general location and time of the tests — offering a clinical examination and advising them how to file a disability claim. It was, in the Congressional Budget Office’s later summary, a September 2006 release from the nondisclosure agreements for the Edgewood program; a broader DoD release covering any chemical and biological testing followed in January 2011. The letter undid the silence. It did not undo the calendar: under 38 U.S.C. § 5110, an award ordinarily cannot take effect earlier than the claim that produced it, so a veteran first permitted to speak in 2006 could be paid, at the earliest, from 2006 — for a disability incurred in 1969.

The class litigation forced the next two concessions. On January 7, 2009, Vietnam Veterans of America and Swords to Plowshares, with individual test subjects including Franklin D. Rochelle and David C. Dufrane, sued the CIA, the Department of Defense, the Army, and VA in the Northern District of California — Vietnam Veterans of America v. Central Intelligence Agency, No. 4:09-cv-00037 — represented pro bono by Morrison & Foerster. They sought no damages, only declaratory and injunctive relief: notice and medical care. Their complaint alleged that at least 7,800 servicemen had been used at Edgewood — a plaintiffs’ allegation, higher than the approximately 7,000 DoD figure VA publishes, recorded here as an allegation rather than an admission. On July 24, 2013, Judge Claudia Wilken resolved the case on summary judgment: the Army, she held, has an ongoing duty to warn, and she ordered it to provide test subjects, through VA or otherwise, with newly acquired information that may affect their well-being, then and in the future. Every other claim was decided for the government — the court found AR 70-25 did impose a duty to provide care, but declined to compel the Army to provide it because VA care was available to some subjects.

The Ninth Circuit corrected half of that. In its opinion filed June 30, 2015, and amended January 26, 2016, the court held AR 70-25’s duty-to-warn provision judicially enforceable and affirmed the notice injunction. On care, it held the district court was right that the regulation imposes a duty to provide medical care — and had no power to decline to compel that care merely because another agency provided similar care to some subjects. It vacated the judgment for the government on the care claim and remanded. On April 4, 2017, the district court entered a Medical Care Injunction requiring the Army to provide care to class members for any injury or disease proximately caused by their participation, with status reports on applications every six months for six years. The headline of 2015 — that the Army owed these men care — became an operating obligation in 2017, forty-two years after the last experiment.

Where it stands now

The last judicial word so far belongs to Bruce Taylor, and it is narrower and larger than the headlines that carried it. Taylor filed in February 2007, after the VA letter reached him; VA granted PTSD and major depressive disorder as a cumulative response to Edgewood and its retraumatization in Vietnam, at a 70 percent rating and then total disability, but with an effective date of February 28, 2007 — the claim date, thirty-five years after discharge. The Board and, in 2019, the Veterans Court refused him an earlier date. On June 15, 2023, the Federal Circuit, sitting en banc, decided Taylor v. McDonough, 71 F.4th 909. The court rejected Taylor’s equitable estoppel argument — Office of Personnel Management v. Richmond bars estoppel to award money contrary to § 5110 — and his argument under 38 U.S.C. § 6303 as well. It then held for him on constitutional grounds: for decades the government had denied him his fundamental right of access to the VA adjudication system, the exclusive forum for his benefits, by threatening court-martial or prosecution with no exception for claims to VA, without adequate justification, when VA itself maintained special processes for claims arising from still-classified special operations. Section 5110’s limits were therefore unconstitutional as applied to him, in what the court expected to be “a very rare set of circumstances.” The remedy is restorative: the effective date he would have had absent the government’s conduct — for Taylor, potentially as early as September 7, 1971, the day after his discharge — with the case remanded to fix that date.

What Taylor did not do is settle the class. It governs veterans who, like Taylor, waited for the oath’s release before filing. In Dufrane v. Collins, No. 25-0702 (Vet. App. Feb. 26, 2026), the Veterans Court held that a veteran who applied before being released is not entitled to an earlier effective date under Taylor — the rule the Congressional Budget Office identifies as the precise gap the pending legislation would close. As of DAV’s September 2026 reporting, Frank Rochelle and Dave Dufrane — plaintiffs in the 2009 case, each already service-connected — still had appeals pending for earlier effective dates. The underlying system is unchanged as VA itself describes it: no presumptive condition list, no registry, claims decided “on a case-by-case basis,” and no test that can confirm an exposure from decades ago.

Congress has the codification in hand and has not passed it. Senator Richard Blumenthal first introduced the Obligations to Aberdeen’s Trusted Heroes Act — the OATH Act — as S. 5324 in the 118th Congress on November 14, 2024; it was referred to the Veterans’ Affairs Committee and went no further. He reintroduced it in the 119th Congress as S. 1665 on May 7, 2025. The bill would codify Taylor — benefits effective from the day after discharge — and require VA to identify the veterans who participated in the Aberdeen and other secrecy oath programs and notify them of their benefits. The committee held hearings on December 10, 2025, and ordered the bill reported on March 18, 2026. CBO estimates $10 million in direct spending over 2026–2036, principally retroactive payments averaging about $50,000 to an estimated 200 veterans who filed before their release — the Dufrane gap — plus $4 million in notification costs. As of October 2026 the bill has been reported from committee; it has not been enacted. The men it concerns volunteered in their late teens and twenties. The youngest are in their seventies.

The ledger

The accounting, in three lines — what the record shows has been done, what it shows has not, and what is still being sought.

What has been done

What has not been done

What is being sought

The record, on video

The Edgewood program filmed itself, and that footage anchors nearly every account since. Four films: the trailer and a clip from the 2022 discovery+ documentary, a documentary on the CIA’s human experiments, and a history of Agent BZ.

The documentary. The official trailer for Dr. Delirium & the Edgewood Experiments (2022): veteran testimony and the Army's own experiment footage, framed by the men who were dosed and the doctor who directed the work. (discovery plus.)

The dose. A press clip released from the same documentary: soldiers at Edgewood receiving their dose, in the program's own footage — the visual record the Army made of its volunteers. (WBD US Nets Press.)

The wider program. The full documentary Codename Artichoke on the CIA's secret experiments on humans, including its account of the Army's LSD experiments at Edgewood Arsenal and the scientists who ran them. (Our Hidden History.)

Agent BZ. A documented history of BZ, the incapacitating agent Edgewood weaponized: the Edgewood tests, the symptoms the Army was seeking, and the weapon that was built and never used. (Into the Shadows.)

Sources

Part of Betrayed, Not Forgotten — this site's accounting for the service members and veterans their own institutions failed. Videos are embedded from their publishers; nothing here is re-hosted.